1. Home
  2. RNST vs VERA Comparison

RNST vs VERA Comparison

Compare RNST & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

N/A

Current Price

$35.90

Market Cap

3.5B

Sector

Finance

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$39.75

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNST
VERA
Founded
1904
2016
Country
United States
United States
Employees
N/A
249
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
RNST
VERA
Price
$35.90
$39.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$42.25
$81.30
AVG Volume (30 Days)
706.2K
988.9K
Earning Date
04-21-2026
05-05-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
N/A
N/A
Revenue This Year
$31.83
N/A
Revenue Next Year
$4.58
$445.28
P/E Ratio
$16.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.26
$18.53
52 Week High
$42.11
$56.05

Technical Indicators

Market Signals
Indicator
RNST
VERA
Relative Strength Index (RSI) 42.64 43.90
Support Level $35.26 $37.20
Resistance Level $37.99 $43.21
Average True Range (ATR) 0.92 2.48
MACD -0.11 0.16
Stochastic Oscillator 44.71 37.19

Price Performance

Historical Comparison
RNST
VERA

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: